Ambuja Cements shares are in focus as consolidation benefits are assessed. Infrastructure order activity is picking up, signaling improving sector visibility. Real estate stocks face a cautious outlook with growth having peaked. Platform companies show sales growth but profitability is a concern. Select pharma names remain attractive for long-term investors.
